Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects. | ||||||||
|
Biologically effective dose in total-body irradiation and hematopoietic stem cell transplantation.Kal HB, Loes van Kempen-Harteveld M, Heijenbrok-Kal MH, Struikmans H Department of Radiotherapy Qoo118, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. H.B.Kal@UMCUtrecht.nl BACKGROUND AND PURPOSE: Total-body irradiation (TBI) is an important part of the conditioning regimen for hematopoietic stem cell transplantation (HSCT) in patients with hematologic malignancies. The results after treatment with various TBI regimens were compared, and dose-effect relationships for the endpoints relapse incidence, disease-free survival, treatment-related mortality, and overall survival were derived. The aim was to define requirements for an optimal treatment schedule with respect to leukemic cell kill and late normal-tissue morbidity. MATERIAL AND METHODS: A literature search was performed. Three randomized studies, four studies comparing results of two or three TBI regimens, and nine reports with results of one specific TBI regimen were identified. Biologically effective doses (BEDs) were calculated. The results of the randomized studies and the studies comparing results of two or three TBI regimens were pooled, and the pooled relative risk (RR) was calculated for the treatments with high BED values versus treatments with a low BED. BED-effect relationships were obtained. RESULTS: RRs for the high BED treatments were significantly lower for relapse incidence, not significantly different for disease- free survival and treatment-related mortality, and significantly higher for overall survival. BED-effect relationships indicate a decrease in relapse incidence and treatment-related mortality and an increase in disease-free and overall survival with higher BED values. CONCLUSION: "More dose is better", provided that a TBI setting is used limiting the BEDs of lungs, kidneys, and eye lenses. Published 30 October 2006 in Strahlenther Onkol, 182(11): 672-9.
© 2004-2008 Radiotherapy Research Today. All Rights Reserved. |
| ||||||
